AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,466 | +55.3% | 23,233 | 0.0% | 0.00% | – |
| Q1 2023 | $6,738 | -35.5% | 23,233 | 0.0% | 0.00% | – |
| Q4 2022 | $10,453 | -12.9% | 23,233 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -7.7% | 23,233 | -7.6% | 0.00% | – |
| Q2 2022 | $13,000 | -96.4% | 25,136 | -84.1% | 0.00% | – |
| Q1 2022 | $362,000 | -52.2% | 157,657 | -1.0% | 0.00% | – |
| Q4 2021 | $757,000 | -40.3% | 159,274 | -0.1% | 0.00% | – |
| Q3 2021 | $1,268,000 | +23.6% | 159,488 | +8.2% | 0.00% | – |
| Q2 2021 | $1,026,000 | -9.6% | 147,401 | +2.9% | 0.00% | – |
| Q1 2021 | $1,135,000 | -4.4% | 143,273 | -5.0% | 0.00% | – |
| Q4 2020 | $1,187,000 | +10.5% | 150,799 | -0.4% | 0.00% | – |
| Q3 2020 | $1,074,000 | -17.5% | 151,388 | +7.6% | 0.00% | – |
| Q2 2020 | $1,302,000 | +193.9% | 140,735 | +48.0% | 0.00% | – |
| Q1 2020 | $443,000 | -35.9% | 95,106 | +5.3% | 0.00% | – |
| Q4 2019 | $691,000 | +0.1% | 90,343 | +0.8% | 0.00% | – |
| Q3 2019 | $690,000 | +5.5% | 89,611 | -6.2% | 0.00% | – |
| Q2 2019 | $654,000 | +32.1% | 95,513 | +55.3% | 0.00% | – |
| Q1 2019 | $495,000 | +33.4% | 61,491 | +24.3% | 0.00% | – |
| Q4 2018 | $371,000 | -12.5% | 49,470 | +11.6% | 0.00% | – |
| Q3 2018 | $424,000 | -3.2% | 44,320 | +7.1% | 0.00% | – |
| Q2 2018 | $438,000 | +508.3% | 41,390 | +212.5% | 0.00% | – |
| Q4 2017 | $72,000 | +10.8% | 13,243 | 0.0% | 0.00% | – |
| Q3 2017 | $65,000 | +27.5% | 13,243 | 0.0% | 0.00% | – |
| Q2 2017 | $51,000 | -67.5% | 13,243 | -37.1% | 0.00% | – |
| Q1 2017 | $157,000 | – | 21,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |